Afficher la notice abrégée

dc.contributor.editorMiyagawa, Shuji
dc.date.accessioned2021-04-20T15:19:37Z
dc.date.available2021-04-20T15:19:37Z
dc.date.issued2012
dc.identifierONIX_20210420_9789533079974_887
dc.identifier.urihttps://directory.doabooks.org/handle/20.500.12854/65530
dc.description.abstractAccompanied by the advent of animal cloning, the technique of nuclear transfer produced alpha1,3-galactosyltransferase-knockout (Gal-KO) pigs in many institutes, including the ones in Japan, at the beginning of 21st Century. In addition, the controversy of the risks of PERV has gradually minimized, because of the fact that there are no cases of PERV infections reported in humans. Furthermore, a large clinical wave for islet allotransplantation resumed the interest of xenotransplantation, especially porcine islet transplantation and some exceptions. Clinical trials were done in many countries so far, such as Sweden, China, Mexico, USA (Inventory of Human Xenotransplantation Practices - IXA and HUG in collaboration with WHO). In addition, a new clinical trial was approved by the government, and resumed the porcine islet transplantation research in New Zealand two years ago.
dc.languageEnglish
dc.subject.classificationthema EDItEUR::M Medicine and Nursing::MN Surgery::MNJ Vascular surgeryen_US
dc.subject.otherPlastic & reconstructive surgery
dc.titleXenotransplantation
dc.typebook
oapen.identifier.doi10.5772/1514
oapen.relation.isPublishedBy78a36484-2c0c-47cb-ad67-2b9f5cd4a8f6
oapen.relation.isbn9789533079974
oapen.relation.isbn9789535167877
oapen.imprintIntechOpen
oapen.pages140


Fichier(s) constituant ce document

FichiersTailleFormatVue

Il n'y a pas de fichiers associés à ce document.

Ce document figure dans la(les) collection(s) suivante(s)

Afficher la notice abrégée

https://creativecommons.org/licenses/by/3.0/
Excepté là où spécifié autrement, la license de ce document est décrite en tant que https://creativecommons.org/licenses/by/3.0/